These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28883288)

  • 1. [The evidence and topics for the diagnosis of hepatocellular carcinoma].
    Nishimura T; Iijima H
    Nihon Shokakibyo Gakkai Zasshi; 2017; 114(9):1593-1601. PubMed ID: 28883288
    [No Abstract]   [Full Text] [Related]  

  • 2. Copper and hepatocellular carcinoma.
    Nakakoshi T
    Radiology; 2000 Jan; 214(1):304-6. PubMed ID: 10644143
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current evidence and topics of diagnosis and treatment for hepatocellular carcinoma].
    Hasegawa K; Kokudo T; Kokudo N
    Nihon Shokakibyo Gakkai Zasshi; 2017; 114(9):1585-1592. PubMed ID: 28883287
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clear cell hepatocellular carcinoma: significance of CK 19].
    Leroy X; Moukassa D; Gosselin B
    Ann Pathol; 1998 Dec; 18(6):512-3. PubMed ID: 10051922
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature.
    Qin LX; Tang ZY
    J Cancer Res Clin Oncol; 2004 Sep; 130(9):497-513. PubMed ID: 15205947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gpc-3 is a notable diagnostic, prognostic and a latent targeted therapy marker in hepatocellular carcinoma.
    Zou ZQ; Ding YP; Long B; Yuh JG; Xu AL; Lang ZW; Zou SY; Liu YD; Ding K; Li YY
    Hepatogastroenterology; 2010; 57(102-103):1285-90. PubMed ID: 21410073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging characterization of hepatocellular carcinoma expressing progenitor cell markers.
    Ward SC; Rosen A
    Liver Int; 2012 Mar; 32(3):349-51. PubMed ID: 22309102
    [No Abstract]   [Full Text] [Related]  

  • 8. [Imaging diagnosis of hepatocellular carcinoma].
    Suyama M; Ariyama J
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():236-41. PubMed ID: 11761946
    [No Abstract]   [Full Text] [Related]  

  • 9. Biopsy diagnosis of hepatocellular carcinoma.
    Caturelli E; de Sio I
    Hepatology; 2008 Jun; 47(6):2145; author reply 2146-7. PubMed ID: 18508306
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of CD34 and factor VIII to diagnose hepatocellular carcinoma on fine needle aspirates.
    Gottschalk-Sabag S; Ron N; Glick T
    Acta Cytol; 1998; 42(3):691-6. PubMed ID: 9622689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Medical imaging investigation and project of hepatocellular carcinoma].
    Zhou KR
    Zhonghua Gan Zang Bing Za Zhi; 2003 Sep; 11(9):517-8. PubMed ID: 14552706
    [No Abstract]   [Full Text] [Related]  

  • 12. Marker panels for the diagnosis of small hepatocellular carcinoma, a never-ending story.
    Bioulac-Sage P; Balabaud C
    Clin Res Hepatol Gastroenterol; 2011 Sep; 35(8-9):513-5. PubMed ID: 21703963
    [No Abstract]   [Full Text] [Related]  

  • 13. Imaging in the diagnosis, staging, treatment, and surveillance of hepatocellular carcinoma.
    Szklaruk J; Silverman PM; Charnsangavej C
    AJR Am J Roentgenol; 2003 Feb; 180(2):441-54. PubMed ID: 12540450
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.
    Song ZZ
    Hepatology; 2008 Jun; 47(6):2145-6; author reply 2146-7. PubMed ID: 18508292
    [No Abstract]   [Full Text] [Related]  

  • 15. Surveillance for hepatocellular carcinoma.
    Frenette C
    Clin Adv Hematol Oncol; 2016 Jun; 14(6):407-9. PubMed ID: 27379808
    [No Abstract]   [Full Text] [Related]  

  • 16. [The significance of immunohistochemistry in the investigation of liver neoplasms: differential diagnosis, prognostic markers].
    Pozharisskiĭ KM; Granov DA; Ten VP; Kubaĭbergenova AG; Leenman EE; Rasskazov AI
    Vopr Onkol; 2008; 54(4):417-33. PubMed ID: 18942395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recent progress on diagnostic imaging of liver tumors].
    Itai Y
    Nihon Shokakibyo Gakkai Zasshi; 1993 May; 90(5):1381-9. PubMed ID: 8391601
    [No Abstract]   [Full Text] [Related]  

  • 18. Nanohoneycomb Surface-Enhanced Raman Spectroscopy-Active Chip for the Determination of Biomarkers of Hepatocellular Carcinoma.
    Zhu A; Zhao X; Cheng M; Chen L; Wang Y; Zhang X; Zhang Y; Zhang X
    ACS Appl Mater Interfaces; 2019 Nov; 11(47):44617-44623. PubMed ID: 31689073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging diagnosis and staging of hepatocellular carcinoma.
    Lee JM; Trevisani F; Vilgrain V; Wald C
    Liver Transpl; 2011 Oct; 17 Suppl 2():S34-43. PubMed ID: 21739567
    [No Abstract]   [Full Text] [Related]  

  • 20. Lymphoepithelioma-like cholangiocarcinoma: a mimic of hepatocellular carcinoma on imaging features.
    Liao TC; Liu CA; Chiu NC; Yeh YC; Chiou YY
    World J Gastroenterol; 2015 Apr; 21(13):4089-95. PubMed ID: 25852298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.